Stay updated on Liraglutide Metformin in GDM Women Clinical Trial
Sign up to get notified when there's something new on the Liraglutide Metformin in GDM Women Clinical Trial page.

Latest updates to the Liraglutide Metformin in GDM Women Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe clinical trial record for liraglutide plus metformin versus metformin alone is displayed, with study design, participant criteria, outcomes, results-related information, and supporting documents. The temporary NIH transition notice and 403 error page are no longer shown.SummaryDifference64%

- Check17 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0; the page continues to show a 403 error instead of the study record.SummaryDifference0.2%

- Check31 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 on the ClinicalTrials.gov 403 error page.SummaryDifference0.2%

- Check38 days agoChange DetectedThe site footer revision changes from v3.7.0 to v3.7.1 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check59 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content. This indicates access is restricted or the page is unavailable.SummaryDifference20%

- Check80 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a minor update to the study record. This change does not alter the substance of the study details such as eligibility, interventions, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Liraglutide Metformin in GDM Women Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Liraglutide Metformin in GDM Women Clinical Trial page.